Immobilized protein system for rapid and enhanced multiplexed diagnostics
AssigneeCornell University
InventorsAlexander J.A. TRAVIS, Roy COHEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of detecting a neural injury biomarker in a biological sample. The method includes subjecting a biological sample to an assay according to the present invention that produces a measurable signal and detecting the measurable signal. The presence or absence of the measurable signal indicates the presence or absence of the biomarker in the sample. The present invention also relates to methods of determining the state of a subject's neural injury. The present invention also relates to systems and devices useful in carrying out the methods of the present invention.
Claims18
-51. (canceled)
A system comprising:
- a platform comprising at least one reaction chamber, said at least one reaction chamber comprising:
- biological assay components suitable to react with the presence of a neuron specific enolase (“NSE”) in a biological sample, said biological assay components comprising:
- (i) 2-Phosphoglycerate (“2-PG”), adenosine diphosphate (“ADP”), and luciferin;
- and
- (ii) a plurality of a first tethered enzyme pyruvate kinase and a plurality of a second tethered enzyme luciferase, wherein at least a portion of each of the plurality of the first and second tethered enzymes is immobilized on a surface of a silica nanoparticle in an orientation that optimizes enzymatic activity,
- wherein said biological assay components are positioned in the at least one reaction chamber to permit one or more sequential reactions whereby the NSE, if present in the biological sample, reacts with the 2-PG to produce phosphoenolpyruvate (“PEP”), said PEP and ADP reacting with the first tethered enzyme pyruvate kinase to produce pyruvate and ATP, said ATP reacting with luciferin and luciferase to produce photons of measurable light.
A system comprising:
- a platform comprising at least one reaction chamber and a negative control reaction chamber, wherein said at least one reaction chamber comprises:
- biological assay components suitable to react with the presence of a neuron specific enolase (“NSE”) in a biological sample, said biological assay components comprising:
- (i) 2-Phosphoglycerate (“2-PG”), adenosine diphosphate (“ADP”), and luciferin;
- and
- (ii) a plurality of a first tethered enzyme pyruvate kinase and a plurality of a second tethered enzyme luciferase, wherein at least a portion of each of the plurality of the first and second tethered enzymes is immobilized on a surface of a silica nanoparticle in an orientation that optimizes enzymatic activity,
- wherein said biological assay components are positioned in the at least one reaction chamber to permit one or more sequential reactions whereby the NSE, if present in the biological sample, reacts with the 2-PG to produce phosphoenolpyruvate (“PEP”), said PEP and ADP reacting with the first tethered enzyme pyruvate kinase to produce pyruvate and ATP, said ATP reacting with luciferin and luciferase to produce photons of measurable light.
Dependencies are inferred from the claim text.